SCHEMBL21628666

SCHEMBL21628666

CN(C)C(=O)c1ccc(Oc2ccc(C(F)(F)C(F)(F)C(F)(F)F)cc2)cc1

nearest known ligand 0.66

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HPGD P15428 3/20 0.65
SMN1; SMN2 Q16637 2/20 0.65
ALDH1A1 P00352 1/20 0.65
MEN1 O00255 2/20 0.48
KMT2A Q03164 2/20 0.48
MLYCD O95822 1/20 0.44
SLC6A2 P23975 1/20 0.44
SLC6A4 P31645 1/20 0.44
MAOB P27338 1/20 0.40
AOC3 Q16853 1/20 0.40
TSHR P16473 1/20 0.40
HTT P42858 1/20 0.40
NR1H3 Q13133 1/20 0.40
RAB9A P51151 2/20 0.40
MAPT P10636 1/20 0.40
ATM Q13315 1/20 0.39
EPHX2 P34913 1/20 0.39
NR1H4 Q96RI1 1/20 0.39
MMP14 P50281 1/20 0.39
HSD17B1 P14061 2/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21628444 0.96 HPGD (0.63) HPGDSMN1; SMN2ALDH1A1MEN1KMT2A
SCHEMBL21628748 0.91 HPGD (0.69) HPGDSMN1; SMN2ALDH1A1MEN1KMT2A
SCHEMBL21628557 0.85 HPGD (0.69) HPGDSMN1; SMN2ALDH1A1MEN1KMT2A
SCHEMBL21628469 0.85 LMNA (0.52) HPGDSMN1; SMN2ALDH1A1
SCHEMBL21628382 0.85 SLC6A2 (0.51) HPGDSMN1; SMN2ALDH1A1MEN1KMT2A
SCHEMBL21628628 0.84 ALDH1A1 (0.73) HPGDSMN1; SMN2ALDH1A1MEN1KMT2A
SCHEMBL21656835 0.81 PARP15 (0.51) HPGDSMN1; SMN2ALDH1A1TSHRHTT
SCHEMBL21628820 0.81 HPGD (0.67) HPGDSMN1; SMN2SLC6A2SLC6A4TSHR
SCHEMBL21656806 0.81 LMNA (0.56) HPGDSMN1; SMN2ALDH1A1MEN1KMT2A
SCHEMBL21628561 0.80 PARP10 (0.61) ALDH1A1KMT2AMAOBTSHRMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12600696-B2 Aromatic compounds Xeniopro GmbH (DE) 2026-04-14 US disclosed
US-20230406814-A2 NOVEL AROMATIC COMPOUNDS Xeniopro GmbH (DE) 2023-12-21 US disclosed
US-20230150923-A1 NOVEL AROMATIC COMPOUNDS Xeniopro GmbH (DE) 2023-05-18 US disclosed
US-11591289-B2 Aromatic compounds Xeniopro GmbH (DE) 2023-02-28 US disclosed
US-11591289-B2 Aromatic compounds Xeniopro GmbH (DE) 2023-02-28 US disclosed
US-20220348535-A2 NOVEL AROMATIC COMPOUNDS Xeniopro GmbH (DE) 2022-11-03 US disclosed
US-20210107863-A2 NOVEL AROMATIC COMPOUNDS Xeniopro GmbH (DE) 2021-04-15 US disclosed
US-20200031763-A1 NOVEL AROMATIC COMPOUNDS Xeniopro GmbH (DE) 2020-01-30 US disclosed
US-20200031763-A1 NOVEL AROMATIC COMPOUNDS Xeniopro GmbH (DE) 2020-01-30 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (7 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230150923-A1 NOVEL AROMATIC COMPOUNDS AHR, TYR, MUSK HPGD 2579/4885SMN1; SMN2 796/4885ALDH1A1 717/4885
US-20220348535-A2 NOVEL AROMATIC COMPOUNDS AHR, TYR, MUSK HPGD 2579/4885SMN1; SMN2 796/4885ALDH1A1 717/4885
US-11591289-B2 Aromatic compounds AHR, TYR, MUSK HPGD 2313/4885SMN1; SMN2 1107/4885ALDH1A1 900/4885
US-20210107863-A2 NOVEL AROMATIC COMPOUNDS AHR, TYR, MUSK HPGD 2579/4885SMN1; SMN2 796/4885ALDH1A1 717/4885
US-12600696-B2 Aromatic compounds CCR1, CCRL2, AHR HPGD 3694/4885SMN1; SMN2 919/4885ALDH1A1 929/4885
US-20230406814-A2 NOVEL AROMATIC COMPOUNDS AHR, TYR, MUSK HPGD 2579/4885SMN1; SMN2 796/4885ALDH1A1 717/4885
US-20200031763-A1 NOVEL AROMATIC COMPOUNDS AHR, TYR, MUSK HPGD 2579/4885SMN1; SMN2 796/4885ALDH1A1 717/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.